Allelic variations in the TAP2 and LMP2 genes in Behçet's disease

Tissue Antigens

Volumn 47, Issue 3, 1996, Pages 249-252

  Ishihara, M ^a,b   Ohno, S ^a   Mizuki, N ^a,b   Yamagata, N ^b   Naruse, T ^b   Shiina, T ^b   Kawata, H ^b   Kuwata, S ^c   Inoko, H ^b,d  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b School of Medicine   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Beh et's disease; LMP2; TAP2

Indexed keywords

HLA B ANTIGEN; PEPTIDE;

ALLELE; ANTIGEN PRESENTATION; ARTICLE; BEHCET DISEASE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN PROCESSING;

ALLELES; AMINO ACID SEQUENCE; ATP-BINDING CASSETTE TRANSPORTERS; BEHCET SYNDROME; CYSTEINE ENDOPEPTIDASES; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROTEINS; VARIATION (GENETICS);

EID: 0029965712     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02549.x     Document Type: Article

References (17)

1. Mizushima Y. Recent research into Behçet's disease in Japan. Int J Tissue React 1988: 10: 59-65.
2. Mizuki N, Inoko H, Ando H, et al. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B*5101. Am J Ophthalmol 1993: 116: 406-9.
3. Mizuki N, Inoko H, Mizuki N et al. Human leukocyte antigen serological and DNA typing of Behçet's disease and its primary association with B51. Invest Ophthalmol Vis Sci 1992: 33: 3332-40.
4. Spies T, Cerundolo V, Colonna M et al. Presentation of endogenous viral antigens depends on putative peptide transporter heterodimer. Nature 1992: 355: 644-6.
5. Bahram S, Arnold D, Bresnahan M et al. Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region. Proc Natl Acad Sci U S A 1991: 88: 10094-8.
6. Glynne R, Powis SH, Beck S et al. A proteasome related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 1991: 353: 357-60.
7. Goldberg AL, Rock KI. Proteolysis, proteasomes, and antigen presentation. Nature 1992: 357: 375-9.
8. Powis SH, Mockridge I, Kelly et al. Polymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complex. Proc Natl Acad Sci U S A 1992: 89: 1463-7.
9. Powis SH, Tonks S, Mockridge I, et al. Alleles and haplotypes of the MHC-encoded ABC transporter TAP1 and TAP2. Immunogenetics 1993: 37: 373-80.
10. Cano P, Baxter-Lowe LA. Novel human TAP2*103 allele shows further polymorphism in the ATP-binding domain. Tissue Antigens 1995: 45: 139-42.
11. Kelly A, Powis SH, Glynne R, et al. Second proteasome-related gene in the human MHC class II region. Nature 1991: 353: 667-8.
12. Kuwata S, Yanagisawa M, Saeki H et al. Lack of primary association between transporter associated with antigen processing genes and atopic dermatitis. J Allergy Clin Immunol (in press).
13. Ishihara M, Ohno S, Mizuki N et al. Genetic polymorphisms of the MHC-encoded antigen processing genes (TAP, LMP) in sarcoidosis. Hum Immunol (in press).
14. Burney RO, Pile KD, Gibson K et al. Analysis of the MHC encoded components of the class I antigen processing pathway in ankylosing spondylitis. Ann Rheum Dis 1994: 53: 58-60.
15. Momburg F, Roelse J, Hämmerlling GJ et al. Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J Exp Med 1994: 179: 1613-23.
16. Momburg F, Roelse J, Howard JC et al. Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 1994: 367: 648-51.
17. Falk K, Rötzschke O, Takiguchi M et al. Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behçet's disease. Int Immunol 1995: 7: 223-8.